Thomas Braxton King's most recent trade in Achieve Life Sciences Inc. was a trade of 455,000 Performance Restricted Stock Unit (PRSU) done . Disclosure was reported to the exchange on Sept. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc | Thomas Braxton King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 455,000 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Thomas Braxton King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 455,000 | 455,000 (1%) | 1% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Thomas Braxton King | Director | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 04 Sep 2025 | 139,858 | 315,142 (1%) | 0% | 2.8 | 387,407 | Common Stock |
| Achieve Life Sciences Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Thomas Braxton King | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 455,000 | 455,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Thomas Braxton King | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 195,000 | 195,000 | - | - | Stock Option (right to buy) | |
| Tff Pharmaceuticals Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 1,583 | 1,583 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 1,583 | 1,583 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 3,110 | 3,110 | - | - | Restricted stock units | |
| Achieve Life Sciences Inc | Thomas King Braxton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 24,000 | 24,000 | - | - | Stock Option (right to buy) |